American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

AACE = American Association of Clinical Endocrinologists ACE = American College of Endocrinology DKA = diabetic ketoacidosis EMA = European Medicines Agency FDA = U.S. Food and Drug Administration SGLT-2 = sodium glucosecotransporter 2 T1D = type 1 diabetes T2D = type 2 diabetes.

Saved in:
Bibliographic Details
Published inEndocrine practice Vol. 22; no. 6; pp. 753 - 762
Main Authors Handelsman, Yehuda, Henry, Robert R., Bloomgarden, Zachary T., Dagogo-Jack, Sam, DeFronzo, Ralph A., Einhorn, Daniel, Ferrannini, Ele, Fonseca, Vivian A., Garber, Alan J., Grunberger, George, LeRoith, Derek, Umpierrez, Guillermo E., Weir, Matthew R.
Format Journal Article
LanguageEnglish
Published United States Elsevier Limited 01.06.2016
Online AccessGet full text
ISSN1530-891X
1934-2403
DOI10.4158/EP161292.PS

Cover

More Information
Summary:AACE = American Association of Clinical Endocrinologists ACE = American College of Endocrinology DKA = diabetic ketoacidosis EMA = European Medicines Agency FDA = U.S. Food and Drug Administration SGLT-2 = sodium glucosecotransporter 2 T1D = type 1 diabetes T2D = type 2 diabetes.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1530-891X
1934-2403
DOI:10.4158/EP161292.PS